The Kate Depew Strang Clinic founded by Dr. Elise Strang L’Esperance and opened by first lady Eleanor Roosevelt at the New York Infirmary, is the first clinic for the early detection of cancer.​

First cancer prevention program established at the Kate Depew Strang Clinic.​

First medical facility to introduce Dr. George Papanicolaou’s Pap test.​

First in U.S. to use sigmoidoscopy for early detection of colon cancer.​

Dr. L’Esperance receives the prestigious Lasker Award for Medical Research.​

Strang Director Dr. Emerson Day coauthors the first medical textbook for early detection of cancer.​

The risk-factor analysis concept in cancer screening is first introduced at Strang.​

RCA and Strang design a computer system to support algorithmic risk factor analysis and a patient’s medical record.​

Strang pioneers the training of paramedical personnel to conduct cancer detection examinations based on Strang’s CanScreen™ Program.

With collaborating institutions, Strang is first to conduct a controlled trial of sputum cytology for early detection of lung cancer.

With collaborating institutions, Strang introduces the stool slide test for detection of colon cancer.​

First in U.S. to study trans-rectal sonography for the detection of prostate cancer.

First to demonstrate a DNA-repair deficiency in colon cancer patients and their families.

Specialized breast surveillance program initiated that provides screening, counseling, and research for women with genetic risk factors.

The first National High-risk Registry for women with strong family histories of breast cancer established.​

Affiliates with the New York Hospital-Cornell Medical Center.

Strang Cancer Research Laboratory opens.

Strang-Cornell Breast Center opens.

Strang Research Computing Group is established.

International Conference for Cancer Prevention is established.

Strang Cancer Research Laboratory is relocated to the campus of The Rockefeller University.

Anne Fisher Nutrition Center opened.

Strang Research Computing Group wins Microsoft Healthcare Industry award.

James E. Olson Colon Cancer Detection Center opened.

Strang Research Computing Group, nominated by Bill Gates, receives a Computerworld Smithsonian Award.

Strang Research Computing Group's Genetics Outreach Program Version 2.0 is inducted into the Smithsonian Institution for contributions to technology and society.

Strang leads multicenter trial for colon polyp prevention.

The Strang Cancer Biology Laboratory established at The Rockefeller University.

Strang scientist describes structure of the functional part of the BRCA 1 gene and is featured on the front cover of the journal Cancer Research.

Classification of BRCA gene mutations.

Bone marrow micrometastasis shown to be the strongest predictor of 5-year survival in breast cancer.

Diet alone for the first time shown to cause colon tumors in an experimental model.

Breast cancer cells inhibited by an extract from the Taheebo tree.

Strang Cancer Prevention Institute is established as an independent non-profit entity and continues to fund research to prevent cancer and promote cure through early detection. Co-Founders Michael P. Osborne MD and Merle K. Barash MA AEd, MA Psya

The Dianne Zola Ovarian Cancer Research Fund established by Strang Trustee

Merle K. Barash MA AEd, MA Psya.

Tribute to Mitchell L. Gaynor, MD; Pioneer of Integrative Oncology and former Strang Director of Medical Oncology.​

Completion of randomized trial to improve primary care physicians’ cancer screening recommendations and communication with patients.

Study of educating primary care physicians on cancer screening and prevention using PREVENTION e-newsletters, 2019 to present.

Honoring Dr. May Edward Chinn at a Street Co Naming Ceremony in New York City, a pioneer who studied cytological methods for cancer detection at its earliest stages and a collaborator in developing the Pap Test at Strang.